Hepatobiliary and Pancreatic Function: Physiologic Changes



The normal variation in physiologic parameters of the hepatobiliary system and pancreas should be taken into account when managing an elderly patient. Appreciation of these alterations allows the surgeon to distinguish between expected physiologic variation and intercurrent pathophysiology in the clinical setting. A review of normal versus expected aging hepatobiliary and pancreatic physiology, as well as a review of select pathophysiology, will be presented in these organ systems.


Bile Acid Main Pancreatic Duct Vagal Stimulation Pancreatic Polypeptide Gallstone Formation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Klein AS, Lillemoe KD, Yeo CJ, Pitt HA (1996) Liver, biliary tract, and pancreas. In: O’Leary JP (ed) The physiologic basis of surgery, 2nd edn. Williams & Wilkins, Baltimore, pp 441–478Google Scholar
  2. 2.
    Admirand WH, Small DM (1968) The physicochemical basis of cholesterol gallstone formation in man. J Clin Invest 47:1043–1052PubMedCrossRefGoogle Scholar
  3. 3.
    Popper H (1986) Aging and the liver. Prog Liver Dis 8:659–683PubMedGoogle Scholar
  4. 4.
    Schmucker DL (1990) Hepatocyte fine structure during maturation and senescence. J Electron Microsc Tech 14(2):106–125, ReviewPubMedCrossRefGoogle Scholar
  5. 5.
    Tauchi H, Sato T (1968) Age changes in size and number of mitochondria of human hepatic cells. J Gerontol 23(4):454–461PubMedCrossRefGoogle Scholar
  6. 6.
    Mooney H, Roberts R, Cooksley WGE et al (1985) Alterations in the liver with aging. Clin Gastroenterol 14:757–771PubMedGoogle Scholar
  7. 7.
    Williams D (1996) Age-related changes in O-deethylase and aldrin epoxidase activity in mouse skin and liver microsomes. Age Ageing 25(5):377–380PubMedCrossRefGoogle Scholar
  8. 8.
    Le Couteur DG, McLean AJ (1998) The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis. Clin Pharmacokinet 34(5):359–373PubMedCrossRefGoogle Scholar
  9. 9.
    Junaidi O, Di Bisceglie AM (2007) Aging liver and hepatitis. Clin Geriatr Med 23(4):889–903PubMedCrossRefGoogle Scholar
  10. 10.
    Thompson EN, Williams R (1965) Effect of age on liver function with particular reference to Bromsulphalein excretion. Gut 6:266–269PubMedCrossRefGoogle Scholar
  11. 11.
    Kampmann JP, Sinding J, Møller-Jørgensen I (1975) Effect of age on liver function. Geriatrics 30:91–95PubMedGoogle Scholar
  12. 12.
    Rafsky HA, Newman B (1943) Liver function tests in the aged (the serum cholesterol partition, Bromsulphalein, cephalinflocculation and oral and intravenous hippuric acid tests). Am J Dig Dis 10:66–69CrossRefGoogle Scholar
  13. 13.
    Koff RS, Garvey AJ, Burney SW et al (1973) Absence of an age effect on sulfobromophthalein retention in healthy men. Gastroen­terology 65:300–302PubMedGoogle Scholar
  14. 14.
    Sawada N, Ishikawa T (1988) Reduction of potential for replicative but not unscheduled DNA synthesis in hepatocytes isolated from aged as compared to young rats. Cancer Res 48(6):1618–1622PubMedGoogle Scholar
  15. 15.
    Zapletal Ch, Faust D, Wullstein C, Woeste G et al (2005) Does the liver ever age? Results of liver transplantation with donors above 80 years of age. Transplant Proc 37(2):1182–1185PubMedCrossRefGoogle Scholar
  16. 16.
    Qvist N (1995) Motor activity of the gallbladder and gastrointestinal tract as determinants of enterohepatic circulation: a scintigraphic and manometric study. Dan Med Bull 42:426–440PubMedGoogle Scholar
  17. 17.
    Gadacz TR (1993) Biliary anatomy and physiology. In: Greenfield LJ (ed) Surgery: scientific principles and practice. Lippincott, Philadelphia, pp 925–936Google Scholar
  18. 18.
    Khalil T, Walker JP, Wiener I et al (1985) Effect of aging on gallbladder contraction and release of cholecystokinin-33 in humans. Surgery 98:423–429PubMedGoogle Scholar
  19. 19.
    Rajan M, Wali JP, Sharma MP et al (2000) Ultrasonographic assessment of gall bladder kinetics in the elderly. Indian J Gastroenterol 19(4):158–160PubMedGoogle Scholar
  20. 20.
    Nagase M, Hikasa Y, Soloway RD et al (1980) Surgical significance of dilatation of the common bile duct: with special reference to choledocholithiasis. Jpn J Surg 10:296–301PubMedCrossRefGoogle Scholar
  21. 21.
    Kaim A, Steinke K, Frank M, Enriquez R et al (1998) Diameter of the common bile duct in the elderly patient: measurement by ultrasound. Eur Radiol 8(8):1413–1415PubMedCrossRefGoogle Scholar
  22. 22.
    Valdivieso V, Palma R, Wünkhaus R et al (1978) Effect of aging on biliary lipid composition and bile acid metabolism in normal Chilean women. Gastroenterology 74:871–874PubMedGoogle Scholar
  23. 23.
    Bateson MC (1984) Gallbladder disease and cholecystectomy rate are independently variable. Lancet 2:621–624PubMedCrossRefGoogle Scholar
  24. 24.
    Lieber MM (1952) The incidence of gallstones and their correlation with other diseases. Ann Surg 135:394–405PubMedCrossRefGoogle Scholar
  25. 25.
    Lindström CG (1977) Frequency of gallstone disease in a well-defined Swedish population. Scand J Gastroenterol 12:341–346PubMedCrossRefGoogle Scholar
  26. 26.
    Marinovic I, Guerra C, Larach G (1972) Incidencia de litiasis biliar en material de autopsias y analisis de composicion de los calculos. Rev Med Chil 100:1320–1327PubMedGoogle Scholar
  27. 27.
    Heaton KW (1973) The epidemiology of gallstones and suggested aetiology. Clin Gastroenterol 2:67–83PubMedGoogle Scholar
  28. 28.
    Attili AF, Capocaccia R, Carulli N et al (1997) Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis. Hepatology 26(4):809–818PubMedCrossRefGoogle Scholar
  29. 29.
    Wang DC (2002) Aging per se is an independent risk factor for cholesterol gallstone formation in gallstone susceptible mice. J Lipid Res 43(11):1950–1959PubMedCrossRefGoogle Scholar
  30. 30.
    National Center for Health Statistics (1994) National Hospital Discharge Survey: Annual Summary. Series 13: Data from the National Health Care Survey, No. 128. DHHS Publ No. (PHS) 97–1789. National Center for Health Statistics, Hyattsville, MD, May 1997Google Scholar
  31. 31.
    Reiss R, Deutsch AA (1985) Emergency abdominal procedures in patients above 70. J Gerontol 40:154–158PubMedCrossRefGoogle Scholar
  32. 32.
    Tang WH (1996) Serum and bile lipid levels in patients with and without gallstones. J Gastroenterol 31:823–827PubMedCrossRefGoogle Scholar
  33. 33.
    Holan KR, Holzbach RT, Hermann RE et al (1979) Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology 77:611–617PubMedGoogle Scholar
  34. 34.
    Portincasa P, Stolk MFJ, van Erpecum KJ et al (1995) Cholesterol gallstone formation in man and potential treatments of the gallbladder motility defect. Scand J Gastroenterol 30(Suppl 212):63–78CrossRefGoogle Scholar
  35. 35.
    Festi D, Colecchia A, Orsini M et al (1998) Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well). Int J Obes Relat Metab Disord 22(6):592–600PubMedCrossRefGoogle Scholar
  36. 36.
    Shiffman ML, Shamburek RD, Schwartz CC et al (1993) Gallbladder mucin, arachidonic acid, and bile lipids in patients who develop gallstones during weight reduction. Gastroenterology 105(4):1200–1208PubMedGoogle Scholar
  37. 37.
    Schneider H, Sänger P, Hanisch E (1997) In vitro effects of cholecystokinin fragments on human gallbladders: evidence for an altered CCK-receptor structure in a subgroup of patients with gallstones. J Hepatol 26:1063–1068PubMedCrossRefGoogle Scholar
  38. 38.
    Thompson JC, Fried GM, Ogden WS et al (1982) Correlation between release of cholecystokinin and contraction of the gallbladder in patients with gallstones. Ann Surg 195:670–676PubMedCrossRefGoogle Scholar
  39. 39.
    Zhu XG, Greely GH, Newman J et al (1985) Correlation of in vitro measurements of contractility of the gallbladder with in vivo ultrasonographic findings in patients with gallstones. Surg Gynecol Obstet 161:470–472PubMedGoogle Scholar
  40. 40.
    Upp JR, Nealon WH, Singh P et al (1987) Correlation of cholecystokinin receptors with gallbladder contractility in patients with gallstones. Ann Surg 205:641–648PubMedCrossRefGoogle Scholar
  41. 41.
    Carey MC (1993) Pathogenesis of gallstones. Am J Surg 165(4):410–419, ReviewPubMedCrossRefGoogle Scholar
  42. 42.
    Lambou-Gianoukos S, Heller SJ (2008) Lithogenesis and bile metabolism. Surg Clin North Am 88(6):1175–1194PubMedCrossRefGoogle Scholar
  43. 43.
    Einarsson K, Nilsell K, Leijd B, Angelin B (1985) Influence of age on secretion of cholesterol and synthesis of bile acids by the liver. N Engl J Med 313:277–282PubMedCrossRefGoogle Scholar
  44. 44.
    Bowen JC, Brenner HI, Ferrante WA, Maule WF (1992) Gallstone disease: pathophysiology, epidemiology, natural history, and treatment options. Med Clin North Am 76:1143–1157PubMedGoogle Scholar
  45. 45.
    Ahlberg J, Angelin B, Einarsson K (1981) Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment. J Lipid Res 22:410–422PubMedGoogle Scholar
  46. 46.
    Patankar R, Ozmen MM, Bailey IS, Johnson CD (1995) Gallbladder motility, gallstones, and the surgeon. Dig Dis Sci 40:2323–2335PubMedCrossRefGoogle Scholar
  47. 47.
    Anderson DK, Brunicardi FC (1993) Pancreatic anatomy and physiology. In: Greenfield LJ (ed) Surgery: scientific principles and practice. Lippincott, Philadelphia, pp 775–791Google Scholar
  48. 48.
    DiMagno EP, Vay LWG, Summerskill WHJ (1973) Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 288:813–815PubMedCrossRefGoogle Scholar
  49. 49.
    Havel PJ, Taborsky GJ Jr (1989) The contribution of the autonomic nervous system to changes of glucagon and insulin secretion during hypoglycemic stress. Endocr Rev 10(3):332–350, ReviewPubMedCrossRefGoogle Scholar
  50. 50.
    Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complication (DCCT/EDIC) Study Research Group (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2634Google Scholar
  51. 51.
    Lara-Castro C (2008) Intracellular lipid accumulation in liver and muscle and the insulin resistance syndrome. Endocrinol Metab Clin North Am 37(4):841–856PubMedCrossRefGoogle Scholar
  52. 52.
    Viljanen AP (2009) Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance. J Clin Endocrinol Metab 94(1):50–55PubMedCrossRefGoogle Scholar
  53. 53.
    Brunicardi FC, Chaiken RL, Ryan AS et al (1996) Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis. J Clin Endocrinol Metab 81:3566–3572PubMedCrossRefGoogle Scholar
  54. 54.
    Seymour NE, Volpert AR, Lee EL et al (1995) Alterations in hepatocyte insulin binding in chronic pancreatitis: effects of pancreatic polypeptide. Am J Surg 169:105–110PubMedCrossRefGoogle Scholar
  55. 55.
    Spector SA, Frattini JC, Zdankiewicz PD et al (1997) Insulin receptor gene expression in chronic pancreatitis: the effect of pancreatic polypeptide. In: Surgical forum. Proceedings for the 52nd annual sessions of the Owen H. Wangensteen surgical forum; 1997 Oct 12–17; Chicago. Allen, Lawrence, pp 168–171Google Scholar
  56. 56.
    Brunicardi FC, Druck P, Sun YS et al (1988) Regulation of pancreatic polypeptide secretion in the isolated perfused human pancreas. Am J Surg 155:63–69PubMedCrossRefGoogle Scholar
  57. 57.
    Kojima S, Ueno N, Asakawa A et al (2007) A role for pancreatic polypeptide in feeding and body weight regulation. Peptides 28:459–463PubMedCrossRefGoogle Scholar
  58. 58.
    Jayasena CN (2008) Role of gut hormones in obesity. Endocrinol Metab Clin North Am 37(3):769–787PubMedCrossRefGoogle Scholar
  59. 59.
    Kreel L, Sandin B (1973) Changes in pancreatic morphology associated with aging. Gut 14:962–970PubMedCrossRefGoogle Scholar
  60. 60.
    Glaser J, Stienecker K (2000) Pancreas and aging: a study using ultrasonography. Gerontology 46(2):93–96PubMedCrossRefGoogle Scholar
  61. 61.
    Nagai H, Ohtsubo K (1984) Pancreatic lithiasis in the aged. Gastroenterology 86:331–338PubMedGoogle Scholar
  62. 62.
    Laugier R, Sarles H (1985) The pancreas. Clin Gastroenterol 14:749–756PubMedGoogle Scholar
  63. 63.
    Gullo L, Ventrucci M, Naldoni P, Pezzilli R (1986) Aging and exocrine pancreatic function. J Am Geriatr Soc 34:790–792PubMedGoogle Scholar
  64. 64.
    Walsh RM (2006) Innovations in treating the elderly who have biliary and pancreatic disease. Clin Geriatr Med 22(3):545–558PubMedCrossRefGoogle Scholar
  65. 65.
    Spence JC (1921) Some observations on sugar tolerance, with special reference to variations found at different ages. Q J Med 14:314–326CrossRefGoogle Scholar
  66. 66.
    Davidson MB (1979) The effect of aging on carbohydrate metabolism: a review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly. Metabolism 28:688–705PubMedCrossRefGoogle Scholar
  67. 67.
    Bennett PH (1984) Diabetes in the elderly: diagnosis and epidemiology. Geriatrics 39:37–41PubMedGoogle Scholar
  68. 68.
    Taylor R, Agius L (1988) The biochemistry of diabetes. Biochem J 250:625–640PubMedGoogle Scholar
  69. 69.
    Berger D, Crowther RC, Floyd JC Jr et al (1978) Effect of age on fasting plasma levels of pancreatic hormones in man. J Clin Endocrinol Metab 47:1183–1189PubMedCrossRefGoogle Scholar
  70. 70.
    Mazza AD (2008) Insulin resistance syndrome and glucose dysregulation in the elderly. Clin Geriatr Med 24(3):437–454PubMedCrossRefGoogle Scholar
  71. 71.
    Timiras PS (1994) The endocrine pancreas and carbohydrate metabolism. In: Timiras PS (ed) Physiological basis of aging and geriatrics, 2nd edn. CRC Press, Boca Raton, FL, pp 191–197Google Scholar
  72. 72.
    Goldfine ID (1987) The insulin receptor: molecular biology and transmembrane signaling. Endocr Rev 8:235–255PubMedCrossRefGoogle Scholar
  73. 73.
    Chang AM, Halter JB (2003) Aging and insulin secretion. Am J Physiol Endocrinol Metab 284(1):E7–E12, ReviewPubMedGoogle Scholar
  74. 74.
    Simonson DC, DeFronzo RA (1983) Glucagon physiology and aging: evidence for enhanced hepatic sensitivity. Diabetologia 25:1–7PubMedCrossRefGoogle Scholar
  75. 75.
    Pagano G, Marena S, Scaglione L, Bodoni P et al (1996) Insulin resistance shows selective metabolic and hormonal targets in the elderly. Eur J Clin Invest 26(8):650–656PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of SurgeryBaylor College of MedicineHoustonUSA

Personalised recommendations